In Situ Genetic Correction of the Sickle Cell Anemia Mutation in Human Induced Pluripotent Stem Cells Using Engineered Zinc Finger Nucleases

The combination of induced pluripotent stem (iPS) cell technology and targeted gene modification by homologous recombination (HR) represents a promising new approach to generate genetically corrected, patient-derived cells that could be used for autologous transplantation therapies. This strategy ha...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Sebastiano, Vittorio, Maeder, Morgan L., Angstman, James F., Haddad, Bahareh, Khayter, Cyd, Yeo, Dana T., Goodwin, Mathew J., Hawkins, John S., Ramirez, Cherie L., Batista, Luis F.Z., Artandi, Steven E., Wernig, Marius, Joung, J. Keith
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2011
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3285772/
https://ncbi.nlm.nih.gov/pubmed/21898685
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/stem.718
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge